Telbivudine contraindications: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Telbivudine}} {{CMG}} ==Contraindications== Combination of Tyzeka with pegylated interferon alfa-2a is contraindicated because of increased risk of peripheral neu...") |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Telbivudine}} | {{Telbivudine}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{SS}} | ||
==Contraindications== | ==Contraindications== | ||
Combination of Tyzeka with [[pegylated interferon alfa-2a]] is contraindicated because of increased risk of [[peripheral neuropathy]] [see Warnings and Precautions (5.4) and Drug Interactions (7)].<ref>{{Cite web | last = | first =|title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022011s013lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022011s013lbl.pdf | publisher = |date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
| Line 12: | Line 12: | ||
{{FDA}} | {{FDA}} | ||
[[Category: | [[Category:Antibiotics]] | ||
[[Category:Wikinfect]] | [[Category:Wikinfect]] | ||
Latest revision as of 20:42, 2 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Contraindications
Combination of Tyzeka with pegylated interferon alfa-2a is contraindicated because of increased risk of peripheral neuropathy [see Warnings and Precautions (5.4) and Drug Interactions (7)].[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022011s013lbl.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.